Table of Contents 3
List of Tables 5
List of Figures 5
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
ProMetic Life Sciences Acquires Plasma Collection Center in Canada from Emergent BioSolutions 14
Partnerships 15
Prometic Life Sciences to Form Joint Venture with Shenzhen Royal Asset Management 15
ProMetic Life Sciences Enters into Agreement with ProThera Biologics 16
ProMetic BioSciences Enters Into Co-Development Agreement With Pharma Company 17
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 18
ProMetic Life Sciences Enters Into Joint Venture Agreement With NantPharma 19
ProMetic Life Sciences Enters Into Co-Development Agreement With Hematech Biotherapeutics 20
Licensing Agreements 21
ProMetic Life Sciences Enters into Licensing Agreement with Omnio 21
Ipsen Enters into Licensing Agreement with Telesta Therapeutics 22
BL&H Enters into Licensing Agreement with Telesta Therapeutics 23
ProMetic Life Sciences Enters into Licensing Agreement with Generium 24
ProMetic Life Sciences Enters Into Licensing Agreement With Shenzhen Hepalink Pharma 25
ProMetic Life Sciences Enters Into Licensing Agreement For Its Affinity Resin Technology 26
Paladin Labs Enters Into Licensing Agreement With Bioniche Life Sciences 27
Equity Offering 29
Prometic Life Sciences Raises USD40.2 Million in Public Offering of Shares 29
Prometic Life Sciences Raises USD6.5 Million in Private Placement of Shares 31
ProMetic Life Sciences Raises USD16 Million in Private Placement of Shares upon Exercise of Warrants 32
ProMetic Life Sciences Raises USD3 Million in Private Placement of Shares 33
ProMetic Life Sciences Raises USD47.8 Million in Public Offering of Shares 34
Telesta Therapeutics Raises USD28.3 Million in Private Placement of Shares 36
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 37
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment Option for USD7.5 Million Bought Deal Public Offering of Shares 38
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment of Public Offering of Shares 39
Bioniche Life Sciences Raises USD5.2 Million in Public Offering of Units 41
ProMetic Life Sciences Completes Private Placement Of Shares For US$23 Million 43
Bioniche Life Sciences Completes Private Placement Of Units For US$9.4 Million 45
ProMetic Life Sciences Raises USD10 Million in Pivate Placement Of Shares 47
ProMetic Life Sciences Completes Private Placement Of Shares For US$1 Million 48
Debt Offering 49
ProMetic Life Sciences Raises USD30 Million in Private Placement of 8% Notes Due 2022 49
Acquisition 50
ProMetic Life Sciences Acquires Telesta Therapeutics 50
ProMetic Life Sciences Acquires Additional Stake In NantPro BioSciences 52
ProMetic Life Sciences Inc - Key Competitors 53
ProMetic Life Sciences Inc - Key Employees 54
ProMetic Life Sciences Inc - Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 57
Financial Announcements 57
Aug 14, 2018: Prometic Life Sciences announces second quarter 2018 financial results 57
May 15, 2018: Prometic Announces 2018 first quarter financial results 59
Mar 28, 2018: Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities 61
Nov 13, 2017: Prometic Reports 2017 Third Quarter Highlights and Financial Results 66
Aug 14, 2017: Prometic Reports 2017 Second Quarter Highlights and Financial Results 68
May 15, 2017: Prometic Reports 2017 First Quarter Highlights and Financial Results 70
Mar 30, 2017: Prometic Reports its 2016 Fourth Quarter and Year End Highlights and Financial Results 72
Corporate Communications 75
Apr 03, 2018: Prometic Announces Appointment of Bruce Wendel as Chief Business Development Officer 75
Product News 76
10/20/2017: Prometic Presents In Vivo Data for PBI-4547 at American Association for the Study of Liver Diseases (AASLD) Meeting 76
06/12/2017: Prometic Life Sciences Present Data on PBI-4547 at 2017 American Diabetes Association 77th Scientific Sessions 77
05/08/2017: Prometic to Present New Data on how Plasminogen Reduces Acute Lung Injury at the American Thoracic Society’s 2017 International Conference 78
05/08/2017: Prometic to Present New Data on PBI-4425 at the American Thoracic Society’s 2017 International Conference 79
Product Approvals 80
Mar 05, 2018: Prometic receives Rare Pediatric Disease Designation from U.S. FDA for its Inter-Alpha-Inhibitor-Proteins 80
Feb 15, 2018: Prometic granted orphan drug designation by FDA for Inter-Alpha-Inhibitor-Proteins for treatment of necrotizing enterocolitis (NEC) 81
Aug 29, 2017: Prometic Receives Rare Pediatric Disease Designation From U.S. FDA for its Plasminogen Replacement Therapy 82
Jul 11, 2017: Prometic Announces Positive Long Term Clinical Data on Ryplazym in Plasminogen Congenital Deficiency and Provides Regulatory Update 83
Apr 05, 2017: Prometic completes the filing of its plasminogen Biologics License Application with the U.S. FDA 84
Other Significant Developments 85
Feb 20, 2018: Prometic Announces Realignment of its Clinical Program Priorities for 2018 85
May 10, 2017: Prometic reports its 2017 annual and special meeting of shareholders highlights 87
Apr 07, 2017: Prometic Receives $9.5 Million Purchase Order From Multinational Client 89
Appendix 90
Methodology 90
About GlobalData 90
Contact Us 90
Disclaimer 90

List of Tables
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
ProMetic Life Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 10
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
ProMetic Life Sciences Acquires Plasma Collection Center in Canada from Emergent BioSolutions 14
Prometic Life Sciences to Form Joint Venture with Shenzhen Royal Asset Management 15
ProMetic Life Sciences Enters into Agreement with ProThera Biologics 16
ProMetic BioSciences Enters Into Co-Development Agreement With Pharma Company 17
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 18
ProMetic Life Sciences Enters Into Joint Venture Agreement With NantPharma 19
ProMetic Life Sciences Enters Into Co-Development Agreement With Hematech Biotherapeutics 20
ProMetic Life Sciences Enters into Licensing Agreement with Omnio 21
Ipsen Enters into Licensing Agreement with Telesta Therapeutics 22
BL&H Enters into Licensing Agreement with Telesta Therapeutics 23
ProMetic Life Sciences Enters into Licensing Agreement with Generium 24
ProMetic Life Sciences Enters Into Licensing Agreement With Shenzhen Hepalink Pharma 25
ProMetic Life Sciences Enters Into Licensing Agreement For Its Affinity Resin Technology 26
Paladin Labs Enters Into Licensing Agreement With Bioniche Life Sciences 27
Prometic Life Sciences Raises USD40.2 Million in Public Offering of Shares 29
Prometic Life Sciences Raises USD6.5 Million in Private Placement of Shares 31
ProMetic Life Sciences Raises USD16 Million in Private Placement of Shares upon Exercise of Warrants 32
ProMetic Life Sciences Raises USD3 Million in Private Placement of Shares 33
ProMetic Life Sciences Raises USD47.8 Million in Public Offering of Shares 34
Telesta Therapeutics Raises USD28.3 Million in Private Placement of Shares 36
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 37
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment Option for USD7.5 Million Bought Deal Public Offering of Shares 38
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment of Public Offering of Shares 39
Bioniche Life Sciences Raises USD5.2 Million in Public Offering of Units 41
ProMetic Life Sciences Completes Private Placement Of Shares For US$23 Million 43
Bioniche Life Sciences Completes Private Placement Of Units For US$9.4 Million 45
ProMetic Life Sciences Raises USD10 Million in Pivate Placement Of Shares 47
ProMetic Life Sciences Completes Private Placement Of Shares For US$1 Million 48
ProMetic Life Sciences Raises USD30 Million in Private Placement of 8% Notes Due 2022 49
ProMetic Life Sciences Acquires Telesta Therapeutics 50
ProMetic Life Sciences Acquires Additional Stake In NantPro BioSciences 52
ProMetic Life Sciences Inc, Key Competitors 53
ProMetic Life Sciences Inc, Key Employees 54
ProMetic Life Sciences Inc, Other Locations 55
ProMetic Life Sciences Inc, Subsidiaries 55

List of Figures
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10